Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06740396 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevalence and Severity of Depression in Coronary Artery Disease Patients

Study acronym: PAD-CAD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 18, 2025 (before its estimated April 20, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Site contact updatedv6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v5
  3. Site contact updatedv4
  4. Start date: Jan 10, 2025 to Feb 20, 2025
    • Primary completion date: Mar 20, 2025 to Apr 20, 2025
    • Study completion date: Mar 30, 2025 to Apr 30, 2025
    • Site contact updated
    v3
  5. Study completion date: Mar 20, 2025 to Mar 30, 2025
    • Start date: Dec 20, 2024 to Jan 10, 2025
    • Site contact updated
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational study aims to estimate the prevalence and severity of depression among patients with coronary artery disease (CAD) in Baghdad, Iraq, using the self-administered PHQ-9 questionnaire. The study seeks to answer the following questions: What is the prevalence of depression among CAD patients? How is the severity of depression distributed within this group? Are specific demographic, clinical, or environmental factors associated with higher levels of depression? Participants will: Complete the PHQ-9 to assess the severity of depressive symptoms at a specific point in time. Provide demographic and clinical information, including age, gender, socioeconomic status, comorbidities, and CAD-related factors such as type of intervention and duration of illness, to explore potential correlations with depression.
Trial Details
NCT Number NCT06740396
Lead Sponsor Al-Nahrain University
Conditions
(from sponsor)		 Depression - Major Depressive Disorder
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov